Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,201) with videos related to
Page
of 121
Sort By:
The Journal of Experimental Medicine
|
December 2, 2021
Gut microbiota-driven brain Aβ amyloidosis in mice requires microglia
Hemraj B Dodiya, Holly L Lutz, Ian Q Weigle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2008
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V Cideciyan, Tomas S Aleman, Sanford L Boye, et al.
Environmental Health Perspectives
|
March 23, 2004
Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment
Jeffrey A Kramer, Syril D Pettit, Rupesh P Amin, et al.
The Journal of Pediatrics
|
July 15, 2009
Atherosclerosis in survivors of Kawasaki disease
Monesha Gupta-Malhotra, Dorota Gruber, Seena S Abraham, et al.
Lancet (London, England)
|
September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study
Paul Yang, Laura P Pardon, Allen C Ho, et al.
Circulation. Cardiovascular Genetics
|
June 11, 2017
Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry
Mary J Roman, Richard B Devereux, Liliana R Preiss, et al.
American Heart Journal
|
September 26, 2007
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
Ronald V Lacro, Harry C Dietz, Lisa M Wruck, et al.
Human Gene Therapy
|
September 1, 2006
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis
Samuel G Jacobson, Sanford L Boye, Tomas S Aleman, et al.
JACC. Advances
|
July 18, 2025
Minimum Core Data Elements for Evaluation of Thoracic Aortic Disease
Andreina Carbone, Mary J Roman, Melissa L Russo, et al.
American Journal of Medical Genetics. Part A
|
February 28, 2013
GenTAC registry report: gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection
Kathryn W Holmes, Cheryl L Maslen, Mark Kindem, et al.
Page
of 121
Search research articles
Search
Showing results (1161-1170 of 1,201) with videos related to
Sort By:
Page
of 121
The Journal of Experimental Medicine
|
December 2, 2021
Gut microbiota-driven brain Aβ amyloidosis in mice requires microglia
Hemraj B Dodiya, Holly L Lutz, Ian Q Weigle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2008
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V Cideciyan, Tomas S Aleman, Sanford L Boye, et al.
Environmental Health Perspectives
|
March 23, 2004
Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment
Jeffrey A Kramer, Syril D Pettit, Rupesh P Amin, et al.
The Journal of Pediatrics
|
July 15, 2009
Atherosclerosis in survivors of Kawasaki disease
Monesha Gupta-Malhotra, Dorota Gruber, Seena S Abraham, et al.
Lancet (London, England)
|
September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study
Paul Yang, Laura P Pardon, Allen C Ho, et al.
Circulation. Cardiovascular Genetics
|
June 11, 2017
Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry
Mary J Roman, Richard B Devereux, Liliana R Preiss, et al.
American Heart Journal
|
September 26, 2007
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
Ronald V Lacro, Harry C Dietz, Lisa M Wruck, et al.
Human Gene Therapy
|
September 1, 2006
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis
Samuel G Jacobson, Sanford L Boye, Tomas S Aleman, et al.
JACC. Advances
|
July 18, 2025
Minimum Core Data Elements for Evaluation of Thoracic Aortic Disease
Andreina Carbone, Mary J Roman, Melissa L Russo, et al.
American Journal of Medical Genetics. Part A
|
February 28, 2013
GenTAC registry report: gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection
Kathryn W Holmes, Cheryl L Maslen, Mark Kindem, et al.
Page
of 121